US agencies, funders such as the Gates Foundation, and agribusiness giant Monsanto are trying to force unwilling African nations to accept expensive and insufficiently tested Genetically Modified (GM)
Genetic engineering has been hailed as a panacea for the problem of global hunger and population explosion, but research studies reveal that it has failed to deliver the goods. At the same time, it has created more problems than it could solve. The Union of Concerned Scientists, an international research group based in the US, said none of the genetically engineered crops under cultivation so far has boosted farm yield or overcome the problem of drought conditions. “Genetic engineering has actually done very little to increase the yield of food and feed crops. It appears unlikely that this technology will play a leading role in helping the world feed itself in the foreseeable future,” said the Union of Concerned Scientists. In a document — Failure to Yield — released at the CoP-11, the research group reviewed the data on soybeans and corn, the main GE food/feed crops in the USA.
India will push against punitive action being taken on countries failing to implement the Cartagena Protocol on bio-safety norms, till they frame domestic laws for the purpose. India has decided to take
This paper explores how the Cartagena Protocol to the convention on Biological Diversity, as well as other important drivers, have affected the regulation of genetically engineered (GE) crops in developing countries. It examines the impact of biosafety regulation on research and development of GE crops and on product approvals.
The EU's Joint Research Centre (JRC) has published the proceedings of a workshop on socio-economic impacts of genetically modified (GM) crops. The report finds that there is insufficient evidence for a
<p>This paper assesses the global economic implications of the proposed strict documentation requirements on traded shipments of potentially genetically modified (GM) commodities under the Cartagena Protocol on Biosafety.
The financial mechanism of the Convention on Biological Diversity (CBD), operated by the GEF, has assisted eligible countries to implement their commitments for achieving the objectives of this unique international legal instrument. Considering that most of the biological diversity is located in developing countries, the importance of the GEF to the CBD remains fundamental. This publication highlights the achievements of the GEF since its inception, summarizes its current investment strategy, and begins to map the way forward for the next phase of the GEF.
The issue of living modified organisms (<font class="UCASE">lmo</font>s) figured prominently at a recent meeting of the countries signatory to the Cartagena Protocol for Biosafety. The meeting took 18 decisions on requirements for handling, transport and identification of <font class="UCASE">lmo</font>s during trans-boundary movements. Risk assessment and liability were among other concerns addressed.<br>
This article examines the divergent political responses to unplanned exposure to genetically modified organisms (GMOs) in the Global South. Although scientific and domestic political considerations have some relevance to explaining different positions among developing countries, trade considerations appear to be a principal driver of GMO policy.
India s decision to ratify Cartagena Protocol evokes mixed response
